Literature DB >> 16286059

Comorbidities among Ohio's nursing home residents with diabetes.

Rosemary E Duffy1, Barbara J Mattson, Matthew Zack.   

Abstract

OBJECTIVE: To determine the magnitude of diabetes mellitus among Ohio nursing home residents and the comorbid conditions affecting residents with diabetes. RESEARCH DESIGN, METHOD, AND SETTINGS: In certified Ohio nursing homes during 1999, 161,723 residents were eligible for this study because they had been admitted for at least 1 day that year, had been assessed using the Centers for Medicaid and Medicare's Minimum Data Set instrument, were 21 years old or older, and had a known sex and race. Eligible residents with diabetes were compared with those without diabetes with respect to comorbidity.
RESULTS: The 25% of residents diagnosed with diabetes were younger, more often male, and more often black than residents without this disorder. Residents with diabetes were also more likely to have cardiovascular diseases; visual problems; foot conditions, including missing limbs; and kidney failure. Residents with diabetes were less likely to have oral problems than residents without diabetes.
CONCLUSION: The Minimum Data Set instrument identifies important comorbidities among nursing home residents with diabetes and allows their disease course to be followed longitudinally. Nursing home residents in Ohio, and presumably in other states, bear a heavy burden from diabetes and significant comorbidities.

Entities:  

Mesh:

Year:  2005        PMID: 16286059     DOI: 10.1016/j.jamda.2005.04.009

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  6 in total

1.  Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies.

Authors:  Nicola D Thompson; Joseph F Perz
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

2.  A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.

Authors:  Guillermo E Umpierrez; Saumeth Cardona; David Chachkhiani; Maya Fayfman; Sahebi Saiyed; Heqiong Wang; Priyathama Vellanki; J Sonya Haw; Darin E Olson; Francisco J Pasquel; Theodore M Johnson
Journal:  J Am Med Dir Assoc       Date:  2017-12-27       Impact factor: 4.669

Review 3.  Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?

Authors:  Ahmed H Abdelhafiz; Alan J Sinclair
Journal:  Aging Dis       Date:  2015-08-01       Impact factor: 6.745

4.  Oral/dental items in the resident assessment instrument - minimum Data Set 2.0 lack validity: results of a retrospective, longitudinal validation study.

Authors:  Matthias Hoben; Jeffrey W Poss; Peter G Norton; Carole A Estabrooks
Journal:  Popul Health Metr       Date:  2016-10-21

5.  Frailty as a predictor of mortality among patients with COVID-19: a systematic review and meta-analysis.

Authors:  Xiao-Ming Zhang; Jing Jiao; Jing Cao; Xiao-Peng Huo; Chen Zhu; Xin-Juan Wu; Xiao-Hua Xie
Journal:  BMC Geriatr       Date:  2021-03-17       Impact factor: 3.921

6.  Management of type 2 diabetes in older people.

Authors:  Ahmed H Abdelhafiz; Alan J Sinclair
Journal:  Diabetes Ther       Date:  2013-04-19       Impact factor: 2.945

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.